Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study

Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study

Background. Pulmonary embolism (PE) is a life-threatening disease. Target-specific anticoagulant rivaroxaban is a direct factor Xa inhibitor that can be safely used without laboratory monitoring. Objective. To investigate the efficacy and safety of rivaroxaban versus warfarin for the treatment of ac...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Huang, Linli Duan, Wenjun He, Cheng Hong, Yehui Guo, Xinni Wang, Nuofu Zhang, Yanghang Chen, Tao Wang, Jian Wang, Chunli Liu
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2020/6813492
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items